Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
13.50
+0.17 (1.28%)
At close: Jun 8, 2026, 4:00 PM EDT
13.24
-0.26 (-1.93%)
After-hours: Jun 8, 2026, 7:15 PM EDT
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $1.92 billion as of June 8, 2026. Its market cap has increased by 212.41% in one year.
Market Cap
1.92B
Enterprise Value
1.75B
1-Year Change
212.41%
Ranking
Category
Stock Price
$13.50
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $1.92B, an increase of 2,155.26%. That is a compound annual growth rate of 55.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 1.92B | 19.39% |
| Dec 31, 2025 | 1.61B | 336.04% |
| Dec 31, 2024 | 368.19M | 330.28% |
| Dec 29, 2023 | 85.57M | -26.01% |
| Dec 30, 2022 | 115.65M | 472.04% |
| Dec 31, 2021 | 20.22M | -54.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurinia Pharmaceuticals | 2.01B |
| Nektar Therapeutics | 1.91B |
| Intellia Therapeutics | 1.88B |
| Mesoblast | 1.88B |
| Harmony Biosciences Holdings | 1.88B |
| ADMA Biologics | 1.87B |
| Mineralys Therapeutics | 1.86B |
| Lakefront Biotherapeutics NV | 1.85B |